Be A Leader in the Early Detection of Cognitive Decline in Your Community

Community pharmacy is ideally positioned to take the lead in providing consumers with education on cognitive health and access to standardized screening.

• Driving cognitive health awareness and improving access to baseline and regular screenings are among the most important and urgent challenges of the 21st century
  
  
• Unlike monitoring blood pressure and other routine tests, consumer access to cognitive screenings is limited today
  
  
• Early diagnosis allows for some forms of cognitive impairment, such as those caused by drug interaction and dosage or a vitamin B12 deficiency, to be reversed 

  
  
• Individuals 55 and older should be screened annually, so cognitive decline can be detected early and modifiable risk factors can be addressed
  
  

Lead the Way and Play a Critical Role in the Early Detection of Cognitive Decline

• Differentiate your pharmacy
• Attract new customers
• Strengthen customer relationships
• Expand market basket with complimentary brain health supplements
  
  

Cognivue is a Computerized Test of Cognitive Function

Cognivue objectively, quantitatively and reliably identifies changes in cognitive function that could be indicative of an impairment that requires physician referral.

Based on FDA-cleared technology and protected by 17 patents, Cognivue was intuitively designed to eliminate testing variables.

• Self-administered
• Five-minute test
• Simple one-page report
• Secure and confidential

What Your Customer Receives: